Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.
Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population. Breast Cancer Res. 2017 Jul 19; 19(1):83.